HomeCLRB • NASDAQ
add
Cellectar Biosciences Inc
Previous close
$5.28
Day range
$5.06 - $5.30
Year range
$4.12 - $67.50
Market cap
16.22M USD
Avg Volume
136.53K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.04M | -55.94% |
Net income | -5.45M | -492.57% |
Net profit margin | — | — |
Earnings per share | -3.39 | -276.67% |
EBITDA | -5.98M | 56.14% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.04M | -57.32% |
Total assets | 13.70M | -53.39% |
Total liabilities | 6.23M | -60.13% |
Total equity | 7.47M | — |
Shares outstanding | 3.19M | — |
Price to book | 1.72 | — |
Return on assets | -101.51% | — |
Return on capital | -167.43% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.45M | -492.57% |
Cash from operations | -5.12M | 63.82% |
Cash from investing | — | — |
Cash from financing | 2.25M | 225,137,900.00% |
Net change in cash | -2.86M | 79.78% |
Free cash flow | -3.90M | 82.12% |
About
Founded
1996
Headquarters
Website
Employees
11
